Viewing StudyNCT00022490



Ignite Creation Date: 2024-05-05 @ 11:23 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00022490
Status: TERMINATED
Last Update Posted: 2016-01-07
First Post: 2001-08-10

Brief Title: Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia
Sponsor: OHSU Knight Cancer Institute
Organization: OHSU Knight Cancer Institute

Key Dates - Follows AllAPIJSON File Order

Start Date: 2001-06
Start Date Type: None
Primary Completion Date: 2011-05
Primary Completion Date Type: ACTUAL
Completion Date: 2011-07
Completion Date Type: ACTUAL
First Submit Date: 2001-08-10
First Submit QC Date: January 26 2003
Study First Post Date: 2003-01-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2012-07-11
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-12-08
Last Update Post Date: 2016-01-07
Last Update Post Date Type: ESTIMATED